Soriatane Related Published Studies
Well-designed clinical trials related to Soriatane (Acitretin)
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). [2011.08.31]
Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. [2010.11.30]
Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. [2010.04]
Development, evaluation and clinical studies of Acitretin loaded nanostructured
lipid carriers for topical treatment of psoriasis. [2010]
Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo
controlled study. [2010]
Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type. [2009.04]
Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial. [2009.04]
Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. [2009.03]
Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial. [2008.09.02]
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. [2008.06]
A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis. [2008]
Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. [2007.05]
Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. [2007.01.29]
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. [2006.08]
Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. [2003.09]
The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy. [2003]
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. [2002.11]
Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release. [2000.11]
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. [1998.11.15]
The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. [1998.09]
The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. [1998.01]
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. [1995.08]
Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. [1994.02]
Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. [1992.11]
A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease. [1992]
Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. [1991.10]
Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. [1991.04]
Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. [1991.03]
Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. [1990.04]
A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. [1989.07]
Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients. [1989]
Pustulosis palmo-plantaris. Clinical and histological changes during etretin (acitretin) therapy. [1989]
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. [1989]
Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. [1988.12]
Food increases the bioavailability of acitretin. [1988.11]
Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate. [1988.11]
Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. [1988.09]
Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. [1988]
Well-designed clinical trials possibly related to Soriatane (Acitretin)
[Randomized controlled trials for treatment of 30 cases of ordinary psoriasis by acupuncture and moxibustion]. [2011.02]
The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris. [2010.07]
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. [2005.08]
Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. [2005.03]
Ligand-specific and non-specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP). [1989.04]
Treatment of psoriasis with etretin: a preliminary report. [1987.12]
Other research related to Soriatane (Acitretin)
Efficacy of low-dose acitretin in the treatment of psoriasis. [2011.07.25]
Clinical and histopathological response to acitretin therapy in lipoid proteinosis. [2011.06]
Generalized linear porokeratosis: a rare entity with excellent response to acitretin. [2011.05.15]
Depression and acitretin: a true association or a class labeling? [2011.04]
Acitretin revisited in the era of biologics. [2011.04]
Blastomycosis-like pyoderma in association with recurrent vesicular hand eczema: good response to acitretin. [2011.03.15]
Acitretin revisited. [2011.03]
A case of lichen amyloidosus treated with acitretin. [2011.03]
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin. [2011.02]
Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? [2011.01]
Treatment of congenital ichthyosis with acitretin: a case report. [2010.12]
Langerhans cell histiocytosis in an adult: good response of cutaneous lesions to acitretin. [2010.08]
Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin. [2010.06]
A case of subcorneal pustular dermatosis in association with monoclonal IgA gammopathy successfully treated with acitretin. [2010.03]
Syntheses and evaluation of the antioxidant activity of acitretin analogs with amide bond(s) in the polyene spacer. [2010.01]
A review of acitretin for the treatment of psoriasis. [2009.11]
Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. [2009.11]
Repigmentation and curling of hair after acitretin therapy. [2009.08]
A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects. [2009.07]
Giant condyloma acuminata of Buschke-Lowenstein: successful treatment with a combination of surgical excision, oral acitretin and topical imiquimod. [2009.04]
Evaluation of the efficacy of acitretin therapy for nail psoriasis. [2009.03]
Fulminant hepatic failure following overdose of the vitamin A metabolite acitretin. [2009.02]
Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. [2008.11]
Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. [2008.10]
An unusual cutaneous-polyposis syndrome stabilized with acitretin. [2008.07]
An updated review of acitretin--a systemic retinoid for the treatment of psoriasis. [2008.07]
Acitretin for lichen amyloidosus. [2008.05]
[Acitretin-induced pneumonia: an underestimated complication of treatment of psoriasis] [2008.05]
Erythroderma in a patient taking acitretin for plaque psoriasis. [2008.04]
Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin. [2008.03]
Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse. [2008.01]
Concurrent use of methotrexate and acitretin revisited. [2008]
Hyperkeratosis of the nipple and areola: 2 years of remission with low-dose acitretin and topical calcipotriol therapy. [2008]
Clinical investigation of acitretin in children with severe inherited keratinization disorders in China. [2008]
Acitretin is a safe treatment option for infantile pustular psoriasis. [2008]
A case of Ferguson-Smith type multiple keratoacanthomas associated with keratoacanthoma centrifugum marginatum: response to oral acitretin. [2007.11]
Acquired kinking of the hair caused by acitretin. [2007.09]
Successful treatment of Hailey-Hailey disease with acitretin. [2007.07]
Acitretin-induced subungual hemorrhage. [2007.05]
Acitretin induces capillary leak syndrome in a patient with pustular psoriasis. [2007.02]
Multiple verrucous carcinomas treated with acitretin. [2007.02]
Successful treatment of lichen amyloidosis with combined bath PUVA photochemotherapy and oral acitretin. [2007.01]
Acitretin treatment in acrokeratosis verruciformis of Hopf. [2007]
Severe ichthyosis-related disorders in children: response to acitretin. [2007]
Recurrent dysphonia and acitretin. [2006.12]
Multiple palmar keratoacanthomas treated with acitretin. [2006.11]
The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study. [2006.09]
Acitretin induced bipedal edema. [2006.05]
Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. [2006.02]
Combination therapy with acitretin for psoriasis. [2006]
Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series. [2006]
Connexin 26 (GJB2) mutations in two Swedish patients with atypical Vohwinkel (mutilating keratoderma plus deafness) and KID syndrome both extensively treated with acitretin. [2006]
Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. [2005.11]
Ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome treated with acitretin. [2005.11]
Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare association showing excellent response to acitretin. [2005.09]
Papillon-Lefevre syndrome treated with acitretin. [2005.08]
A review of acitretin, a systemic retinoid for the treatment of psoriasis. [2005.08]
|
